Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
3.490
+0.160 (+4.80%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Macrogenics
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
May 09, 2024
Via
Benzinga
Masters In Trading - Saturday, April 27
April 27, 2024
In this recap of the most recent trading session, I review my portfolio and share one of the trades taken this week.
Via
Talk Markets
Look Out For These 6 Stocks As Analysts Predicts Major Gains, One Up To 82%
April 05, 2024
Investment analysts have revised their price targets upwards for six major stocks this week, with one company expected to see an 82% surge. The revised targets include four U.S.-listed companies, with...
Via
Benzinga
MacroGenics Analyst Impressed By Improved Safety Profile From Prostate Cancer Candidate
April 04, 2024
Update on MacroGenics Inc's Phase 2 TAMARACK study of vobramitamab duocarmazine (vobra duo) for metastatic castration-resistant prostate cancer (mCRPC). Safety and preliminary efficacy data anticipated...
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
April 04, 2024
Via
Benzinga
The Latest Analyst Ratings For Macrogenics
April 04, 2024
Via
Benzinga
Macrogenics: Q4 Earnings Insights
March 07, 2024
Via
Benzinga
A Preview Of Macrogenics's Earnings
March 06, 2024
Via
Benzinga
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 04, 2024
Shares of STAAR Surgical Company (NASDAQ: STAA) rose sharply during Thursday’s session after the company issued strong preliminary first-quarter net sales guidance. STAAR Surgical shares jumped 13.3%...
Via
Benzinga
Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session
April 04, 2024
U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Analyst Expectations For Macrogenics's Future
March 04, 2024
Via
Benzinga
Decoding 4 Analyst Evaluations For Macrogenics
February 14, 2024
Via
Benzinga
MicroMarvel MacroGenics Confuses Wall Street
February 05, 2024
100% technical buy signals. 15 new highs and up 66.53% last month. 280.00+ Weighted Alpha
Via
Talk Markets
Demystifying Macrogenics: Insights From 5 Analyst Reviews
January 24, 2024
Via
Benzinga
MacroGenics (MGNX) Q4 2023 Earnings Call Transcript
March 08, 2024
MGNX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
MGNX Stock Earnings: Macrogenics Misses EPS for Q4 2023
March 07, 2024
MGNX stock results show that Macrogenics missed analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
March 07, 2024
Via
Benzinga
AMD To Rally Around 16%? Here Are 10 Top Analyst Forecasts For Monday
March 04, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
Surgery Partners Posts Weak Sales, Joins Kosmos Energy, Moderna And Other Big Stocks Moving Lower On Monday
February 26, 2024
U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, Inc. (NASDAQ: SGRY) fell sharply during Monday’s session following weak...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Forecasting The Future: 4 Analyst Projections For Macrogenics
December 20, 2023
Via
Benzinga
Earnings Scheduled For March 7, 2024
March 07, 2024
Companies Reporting Before The Bell • CI&T (NYSE:CINT) is estimated to report quarterly earnings at $0.06 per share on revenue of $106.08 million.
Via
Benzinga
World Acceptance Posts Upbeat Earnings, Joins Kaman, Spirit Airlines And Other Big Stocks Moving Higher On Friday
January 19, 2024
U.S. stocks traded higher, with the Dow Jones index gaining around 50 points on Friday. Shares of World Acceptance Corporation (NASDAQ: WRLD) rose sharply during Friday’s session following upbeat...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
The 3 Most Undervalued Biotech Stocks to Buy in January
January 15, 2024
These are a number of undervalued biotech companies that investor should possibly look to add to their portfolios.
Via
InvestorPlace
Why Steelcase Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
December 20, 2023
Steelcase Inc. (NYSE: SCS) shares moved higher during Wednesday's session following quarterly results.
Via
Benzinga
Toro Posts Upbeat Results, Joins Clear Channel Outdoor, Marathon Digital And Other Big Stocks Moving Higher On Wednesday
December 20, 2023
U.S. stocks traded mixed, with the Dow Jones index falling around 50 points on Wednesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Top 4 Health Care Stocks That May Crash This Month
December 20, 2023
As of Dec. 20, 2023, four stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions.
Via
Benzinga
EnerSys To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
December 20, 2023
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
7 Undervalued Biotech Stocks That are Flying Under the Clinical Radar
December 17, 2023
While the broader healthcare sector offers myriad opportunities, these undervalued biotech picks could offer robust upside.
Via
InvestorPlace
Why Sanmina Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
November 07, 2023
Gainers PaxMedica, Inc. (NASDAQ: PXMD) shares climbed 173.8% to $8.35. PaxMedica announced the publication of its autism spectrum disorder Phase 2 study results in the Annals of General Psychiatry.
Via
Benzinga
Datadog, Tripadvisor, Myriad Genetics, Planet Fitness And Other Big Stocks Moving Higher On Tuesday
November 07, 2023
U.S. stocks traded mostly higher, with the Nasdaq Composite gaining around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.